Deals
Coronado Biosciences Raises $10M, Forms Subsidiary
|
Coronado Biosciences (NASDAQ: CNDO) has raised $10 million in a three-year non-convertible promissory note offering featuring an 8% coupon. National Securities Corp. was the agent.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/228/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
Coronado Biosciences (NASDAQ: CNDO) has raised $10 million in a three-year non-convertible promissory note offering featuring an 8% coupon. National Securities Corp. was the agent.
Vapor Corp. (OTC: VPCO) raised $3.51 million in a common stock transaction. The transaction involved a plan allowing Vapor to merge with Vaporin, another provider of "vaping" products. The companies provide equipment for vaporization of inhaled substances, a business that has seen significant growth in recent years. Vapor's product line includes emagine vapor, Krave, VaporX and Hookah Stix.
Threshold Pharmaceuticals (NASDAQ:THLD) announced pricing on a $30 million financing at market.
Transition Therapeutics ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced that it has commenced an underwritten public offering of its common shares for total gross proceeds of US$20 million.